Abstract
BackgroundThe cGAS-STING pathway, which is crucial in antitumor immunotherapy, has been a research focus in developing STING agonists for cancer immunotherapy. However, the use of these agonists in clinical applications...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have